Motif ID: Wrnip1_Mta3_Rcor1
Z-value: 3.002



Transcription factors associated with Wrnip1_Mta3_Rcor1:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Mta3 | ENSMUSG00000055817.11 | Mta3 |
Rcor1 | ENSMUSG00000037896.11 | Rcor1 |
Wrnip1 | ENSMUSG00000021400.6 | Wrnip1 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Rcor1 | mm10_v2_chr12_+_111039334_111039400 | -0.29 | 2.4e-01 | Click! |
Mta3 | mm10_v2_chr17_+_83706170_83706200 | -0.14 | 5.9e-01 | Click! |
Wrnip1 | mm10_v2_chr13_+_32802007_32802152 | -0.01 | 9.7e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.4 | GO:0097402 | neuroblast migration(GO:0097402) |
2.7 | 2.7 | GO:0060067 | cervix development(GO:0060067) |
2.4 | 7.1 | GO:0060166 | olfactory pit development(GO:0060166) |
2.1 | 10.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
2.1 | 6.2 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
2.0 | 10.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
2.0 | 10.1 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.0 | 5.9 | GO:0021759 | globus pallidus development(GO:0021759) |
1.9 | 5.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
1.9 | 1.9 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.8 | 3.6 | GO:0072180 | mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
1.7 | 5.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.7 | 9.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.6 | 4.9 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
1.6 | 4.8 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
1.6 | 6.3 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
1.6 | 1.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
1.5 | 4.6 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.5 | 7.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
1.5 | 4.4 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
1.5 | 5.8 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
1.4 | 1.4 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
1.4 | 4.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.4 | 5.6 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.4 | 4.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.4 | 5.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
1.4 | 4.1 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
1.3 | 2.6 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
1.3 | 3.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.2 | 7.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
1.2 | 4.9 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
1.2 | 4.9 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
1.2 | 3.6 | GO:0003195 | tricuspid valve formation(GO:0003195) |
1.2 | 2.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.2 | 1.2 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
1.2 | 1.2 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
1.1 | 2.3 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
1.1 | 2.3 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
1.1 | 5.7 | GO:1903609 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
1.1 | 3.4 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.1 | 4.5 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.1 | 4.5 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.1 | 7.9 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
1.1 | 1.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
1.1 | 6.4 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
1.0 | 3.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
1.0 | 2.0 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
1.0 | 3.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.0 | 2.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.0 | 3.9 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
1.0 | 2.9 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
1.0 | 2.9 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
1.0 | 3.9 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
1.0 | 2.9 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.0 | 4.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.0 | 3.8 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.0 | 1.9 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.9 | 0.9 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.9 | 1.9 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.9 | 2.8 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.9 | 6.4 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.9 | 2.7 | GO:0019405 | alditol catabolic process(GO:0019405) |
0.9 | 1.8 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
0.9 | 3.6 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.9 | 0.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.9 | 0.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.9 | 0.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.9 | 1.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.9 | 7.8 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.9 | 0.9 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.9 | 2.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.8 | 3.4 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.8 | 4.2 | GO:0015705 | iodide transport(GO:0015705) |
0.8 | 0.8 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.8 | 3.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.8 | 0.8 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.8 | 2.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.8 | 2.5 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.8 | 3.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.8 | 4.9 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.8 | 7.2 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.8 | 2.4 | GO:0003360 | brainstem development(GO:0003360) |
0.8 | 1.6 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.8 | 2.4 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.8 | 0.8 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.8 | 5.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.8 | 3.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.8 | 2.3 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.8 | 2.3 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.8 | 6.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.8 | 4.6 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.8 | 2.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.8 | 3.0 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.8 | 3.8 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.8 | 4.5 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.8 | 1.5 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.8 | 2.3 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.7 | 6.7 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.7 | 2.9 | GO:0072185 | canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.7 | 5.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 2.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.7 | 1.4 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.7 | 1.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.7 | 1.4 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.7 | 3.5 | GO:0015871 | choline transport(GO:0015871) |
0.7 | 2.1 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.7 | 1.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.7 | 2.8 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.7 | 2.1 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.7 | 2.1 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.7 | 2.1 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.7 | 0.7 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
0.7 | 3.4 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.7 | 5.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.7 | 2.7 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.7 | 2.7 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.7 | 1.3 | GO:0060242 | contact inhibition(GO:0060242) |
0.7 | 5.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.7 | 1.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.7 | 3.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.7 | 2.6 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.7 | 0.7 | GO:0060066 | oviduct development(GO:0060066) |
0.7 | 3.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.7 | 1.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.7 | 0.7 | GO:0014028 | notochord formation(GO:0014028) |
0.7 | 4.6 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.7 | 0.7 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.6 | 6.5 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.6 | 3.2 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.6 | 2.6 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.6 | 3.2 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.6 | 1.9 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.6 | 1.9 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.6 | 2.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.6 | 2.5 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 1.9 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.6 | 3.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.6 | 5.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.6 | 4.3 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.6 | 3.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.6 | 1.8 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.6 | 9.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.6 | 1.2 | GO:1990523 | bone regeneration(GO:1990523) |
0.6 | 0.6 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.6 | 1.8 | GO:0051940 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.6 | 1.8 | GO:1990046 | positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
0.6 | 1.8 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.6 | 1.8 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.6 | 1.8 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.6 | 0.6 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.6 | 0.6 | GO:0060214 | endocardium formation(GO:0060214) |
0.6 | 1.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.6 | 1.8 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.6 | 1.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.6 | 1.2 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.6 | 3.6 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.6 | 3.0 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
0.6 | 5.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 1.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.6 | 2.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.6 | 4.1 | GO:1905214 | regulation of RNA binding(GO:1905214) |
0.6 | 0.6 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.6 | 2.9 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.6 | 2.9 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.6 | 2.9 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.6 | 5.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.6 | 5.2 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.6 | 0.6 | GO:0031342 | negative regulation of cell killing(GO:0031342) |
0.6 | 1.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.6 | 0.6 | GO:0046878 | regulation of saliva secretion(GO:0046877) positive regulation of saliva secretion(GO:0046878) |
0.6 | 6.3 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.6 | 2.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.6 | 5.7 | GO:0070472 | regulation of uterine smooth muscle contraction(GO:0070472) |
0.6 | 4.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.6 | 1.7 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.6 | 1.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.6 | 3.4 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.6 | 1.7 | GO:0001705 | ectoderm formation(GO:0001705) |
0.6 | 1.7 | GO:0015938 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
0.6 | 2.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.6 | 0.6 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.6 | 1.7 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.6 | 1.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 0.6 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.6 | 1.7 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.6 | 1.7 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.6 | 0.6 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.6 | 3.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.5 | 2.2 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.5 | 1.6 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.5 | 0.5 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.5 | 1.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.5 | 0.5 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.5 | 1.6 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.5 | 2.2 | GO:0090282 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.5 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.5 | 1.6 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.5 | 2.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.5 | 2.7 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.5 | 1.6 | GO:0051030 | snRNA transport(GO:0051030) |
0.5 | 0.5 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.5 | 1.1 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.5 | 0.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.5 | 0.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.5 | 1.6 | GO:2000768 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.5 | 0.5 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.5 | 2.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.5 | 3.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.5 | 3.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.5 | 1.6 | GO:0030070 | insulin processing(GO:0030070) |
0.5 | 4.7 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.5 | 2.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.5 | 1.0 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.5 | 1.6 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.5 | 0.5 | GO:1902338 | negative regulation of apoptotic process involved in morphogenesis(GO:1902338) negative regulation of apoptotic process involved in development(GO:1904746) |
0.5 | 1.0 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.5 | 2.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.5 | 2.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.5 | 0.5 | GO:0035799 | ureter maturation(GO:0035799) |
0.5 | 6.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 0.5 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.5 | 1.5 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
0.5 | 0.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.5 | 2.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.5 | 0.5 | GO:0021586 | pons maturation(GO:0021586) |
0.5 | 2.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.5 | 2.0 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
0.5 | 0.5 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
0.5 | 0.5 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
0.5 | 0.5 | GO:0090135 | actin filament branching(GO:0090135) |
0.5 | 3.5 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.5 | 3.5 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.5 | 1.0 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.5 | 1.5 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.5 | 1.5 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.5 | 0.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.5 | 0.5 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.5 | 3.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.5 | 3.0 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.5 | 8.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.5 | 0.5 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.5 | 5.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.5 | 1.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.5 | 2.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.5 | 1.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.5 | 1.5 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.5 | 5.3 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.5 | 0.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.5 | 3.9 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.5 | 2.9 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 0.5 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.5 | 1.9 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
0.5 | 1.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.5 | 1.9 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.5 | 2.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.5 | 1.9 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.5 | 3.3 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.5 | 3.8 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.5 | 2.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.5 | 0.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.5 | 0.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.5 | 0.9 | GO:0019081 | viral translation(GO:0019081) |
0.5 | 0.5 | GO:0046364 | hexose biosynthetic process(GO:0019319) monosaccharide biosynthetic process(GO:0046364) |
0.5 | 1.4 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.5 | 0.5 | GO:0060003 | copper ion export(GO:0060003) |
0.5 | 1.4 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.5 | 3.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 2.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.5 | 0.5 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.5 | 2.3 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
0.5 | 0.9 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.5 | 0.5 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.5 | 1.4 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.5 | 1.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 1.4 | GO:0045819 | plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
0.5 | 2.8 | GO:0032796 | uropod organization(GO:0032796) |
0.5 | 4.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.5 | 4.6 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.5 | 1.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.5 | 4.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.5 | 0.5 | GO:0009204 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
0.5 | 3.2 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.5 | 1.8 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.5 | 1.4 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.5 | 4.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 1.4 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.5 | 1.4 | GO:0033122 | regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.5 | 0.9 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.5 | 5.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.5 | 2.3 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.5 | 1.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.4 | 0.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.4 | 4.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 0.4 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.4 | 0.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.4 | 0.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 0.9 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.4 | 2.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.4 | 0.4 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.4 | 3.1 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.4 | 0.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.4 | 1.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 1.3 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.4 | 0.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.4 | 5.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.4 | 2.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.4 | 2.2 | GO:0051012 | microtubule sliding(GO:0051012) |
0.4 | 1.3 | GO:0015747 | urate transport(GO:0015747) |
0.4 | 3.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 6.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.4 | 2.2 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.4 | 1.3 | GO:0035878 | nail development(GO:0035878) |
0.4 | 1.3 | GO:0010248 | B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.4 | 1.3 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.4 | 1.7 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.4 | 4.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 0.9 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.4 | 3.0 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.4 | 1.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.4 | 3.4 | GO:0002118 | aggressive behavior(GO:0002118) |
0.4 | 0.9 | GO:0003032 | detection of oxygen(GO:0003032) |
0.4 | 1.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.4 | 0.4 | GO:0045575 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
0.4 | 0.4 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.4 | 1.7 | GO:0030576 | Cajal body organization(GO:0030576) |
0.4 | 0.8 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.4 | 0.8 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
0.4 | 2.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.4 | 0.4 | GO:0048631 | skeletal muscle tissue growth(GO:0048630) regulation of skeletal muscle tissue growth(GO:0048631) |
0.4 | 2.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.4 | 2.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.4 | 0.4 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.4 | 1.7 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 0.8 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
0.4 | 2.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.4 | 0.8 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.4 | 1.2 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.4 | 1.7 | GO:0015786 | UDP-glucose transport(GO:0015786) |
0.4 | 0.4 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.4 | 0.8 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.4 | 1.6 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.4 | 2.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 0.8 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.4 | 0.8 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.4 | 0.4 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.4 | 2.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.4 | 0.8 | GO:0006507 | GPI anchor release(GO:0006507) |
0.4 | 2.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.4 | 1.2 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.4 | 1.6 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.4 | 8.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 2.0 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.4 | 0.4 | GO:0045628 | regulation of T-helper 2 cell differentiation(GO:0045628) |
0.4 | 0.8 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.4 | 2.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.4 | 1.2 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.4 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 2.4 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.4 | 2.0 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.4 | 1.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 6.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.4 | 2.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.4 | 1.6 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.4 | 1.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.4 | 3.2 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.4 | 1.2 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.4 | 2.4 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.4 | 0.4 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.4 | 1.2 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.4 | 1.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 2.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.4 | 1.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 1.9 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 0.4 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.4 | 0.4 | GO:0051665 | membrane raft localization(GO:0051665) |
0.4 | 1.9 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.4 | 1.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.4 | 1.2 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.4 | 0.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.4 | 1.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.4 | 0.8 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.4 | 0.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.4 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.4 | 1.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.4 | 1.1 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.4 | 1.9 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.4 | 2.6 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.4 | 0.4 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.4 | 1.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.4 | 2.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.4 | 6.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 0.7 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) negative regulation of alkaline phosphatase activity(GO:0010693) |
0.4 | 2.2 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.4 | 1.5 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.4 | 4.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 1.9 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 0.4 | GO:1902074 | response to salt(GO:1902074) |
0.4 | 1.8 | GO:0015669 | gas transport(GO:0015669) |
0.4 | 4.0 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.4 | 0.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.4 | 0.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.4 | 0.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 1.1 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.4 | 0.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.4 | 1.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.4 | 4.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.4 | 1.4 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.4 | 4.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.4 | 1.1 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.4 | 0.4 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.4 | 0.7 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.4 | 0.4 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.4 | 1.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.4 | 2.5 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.4 | 0.7 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.4 | 0.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.4 | 1.1 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.4 | 5.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.4 | 0.4 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.4 | 2.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.4 | 5.0 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.4 | 2.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.4 | 0.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.4 | 1.1 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.4 | 6.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 0.7 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.4 | 0.7 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.4 | 0.4 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.4 | 1.1 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.4 | 1.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 1.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 3.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 0.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.3 | 2.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.3 | 1.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.3 | 7.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.3 | 0.7 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.3 | 2.8 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 5.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 1.0 | GO:1904207 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.3 | 1.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 4.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.3 | 10.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 1.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.3 | 0.7 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.3 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 0.7 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.3 | 1.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 1.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.3 | 0.7 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.3 | 0.7 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.3 | 3.4 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.3 | 0.3 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.3 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 2.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.3 | 1.7 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 0.3 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.3 | 0.3 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 | 0.7 | GO:0021539 | subthalamus development(GO:0021539) |
0.3 | 1.0 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.3 | 1.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.3 | 0.7 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.3 | 1.0 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.3 | 0.3 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.3 | 0.7 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.3 | 2.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.3 | 1.0 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.3 | 2.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 1.0 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.3 | 1.3 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.3 | 3.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.3 | 0.3 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 3.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 3.9 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.3 | 0.7 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.3 | 0.7 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.3 | 0.6 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) negative regulation of receptor catabolic process(GO:2000645) |
0.3 | 1.6 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.3 | 0.3 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.3 | 0.6 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.3 | 1.6 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.3 | 0.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.3 | 1.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.3 | 2.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.3 | 0.3 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.3 | 0.3 | GO:0046471 | cardiolipin metabolic process(GO:0032048) phosphatidylglycerol metabolic process(GO:0046471) |
0.3 | 2.6 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.3 | 0.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 1.0 | GO:0072014 | proximal tubule development(GO:0072014) |
0.3 | 1.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.3 | 0.6 | GO:0048793 | pronephros development(GO:0048793) |
0.3 | 3.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 0.6 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.3 | 0.9 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.3 | 0.3 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.3 | 2.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.3 | 0.3 | GO:1904809 | dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
0.3 | 1.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 0.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.3 | 0.3 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 1.6 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.3 | 0.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.3 | 0.9 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
0.3 | 1.2 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.3 | 2.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 0.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.3 | 6.5 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 0.9 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.3 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.3 | 1.5 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.3 | 0.6 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.3 | 0.6 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.3 | 0.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.3 | 1.8 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.3 | 0.3 | GO:0060438 | trachea development(GO:0060438) |
0.3 | 1.8 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
0.3 | 3.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 1.2 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.3 | 1.8 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.3 | 1.5 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.3 | 0.6 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.3 | 0.3 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.3 | 2.4 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 0.3 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.3 | 0.6 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.3 | 1.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 0.9 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.3 | 0.6 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.3 | 0.6 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.3 | 0.6 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.3 | 0.9 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.3 | 0.3 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.3 | 1.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 0.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 0.9 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.3 | 0.6 | GO:0051132 | NK T cell activation(GO:0051132) |
0.3 | 0.6 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.3 | 1.5 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 6.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 0.9 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.3 | 2.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.3 | 1.5 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.3 | 0.3 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.3 | 3.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 2.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.3 | 1.8 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.3 | 0.9 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
0.3 | 0.9 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.3 | 1.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.3 | 9.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 1.8 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.3 | 2.3 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.3 | 0.9 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.3 | 0.6 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.3 | 0.9 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.3 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.3 | 0.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.3 | 0.9 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.3 | 0.3 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.3 | 0.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.3 | 0.9 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.3 | 5.8 | GO:0006825 | copper ion transport(GO:0006825) |
0.3 | 2.6 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.3 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 5.2 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.3 | 0.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.3 | 0.3 | GO:0042755 | eating behavior(GO:0042755) |
0.3 | 2.9 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.3 | 0.3 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.3 | 1.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.3 | 1.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.3 | 3.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.3 | 1.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.9 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 0.6 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.3 | 2.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 0.9 | GO:0002922 | positive regulation of humoral immune response(GO:0002922) |
0.3 | 0.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.3 | 0.8 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 2.3 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.3 | 0.6 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) positive regulation of protein polyubiquitination(GO:1902916) |
0.3 | 0.6 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.3 | 0.8 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.3 | 0.3 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.3 | 0.3 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.3 | 0.6 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.3 | 2.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 0.3 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.3 | 1.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 2.8 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 2.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 1.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 1.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.3 | 0.5 | GO:0072708 | response to sorbitol(GO:0072708) |
0.3 | 0.3 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.3 | 0.3 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.3 | 0.3 | GO:0044851 | hair cycle phase(GO:0044851) |
0.3 | 1.9 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.3 | 0.3 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.3 | 1.1 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.3 | 0.8 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.3 | 1.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 0.3 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.3 | 1.4 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.3 | 0.3 | GO:0099550 | trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
0.3 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 0.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 1.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 0.5 | GO:0010886 | regulation of cholesterol storage(GO:0010885) positive regulation of cholesterol storage(GO:0010886) |
0.3 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
0.3 | 4.3 | GO:0019835 | cytolysis(GO:0019835) |
0.3 | 0.8 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.3 | 1.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.3 | 1.6 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 1.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 3.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 0.5 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 0.8 | GO:0061357 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.3 | 0.5 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.3 | 3.7 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.3 | 1.9 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 2.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 1.3 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.3 | 1.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 0.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.8 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 0.8 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.3 | 0.8 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.3 | 0.5 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.3 | 2.4 | GO:0031639 | plasminogen activation(GO:0031639) |
0.3 | 1.8 | GO:0045176 | apical protein localization(GO:0045176) |
0.3 | 0.3 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.3 | 0.8 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 3.9 | GO:0050832 | defense response to fungus(GO:0050832) |
0.3 | 1.0 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.3 | 2.9 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.3 | 5.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.6 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 3.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 0.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.3 | 0.5 | GO:1902661 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.3 | 1.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 0.5 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.3 | 2.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.3 | 3.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.3 | 2.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.3 | 0.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.3 | 0.8 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.3 | 0.8 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.3 | 0.3 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 0.3 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.3 | 0.3 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.3 | 0.5 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.3 | 1.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 0.3 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.3 | 0.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.7 | GO:0032692 | negative regulation of interleukin-1 production(GO:0032692) |
0.2 | 0.5 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 1.2 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.2 | 0.7 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 1.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 0.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.2 | 0.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.2 | 1.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 2.7 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.2 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 0.7 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.2 | 1.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.7 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.2 | 0.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 1.9 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
0.2 | 0.7 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 0.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 0.2 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.2 | 2.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 2.9 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.2 | 1.7 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.2 | 1.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.2 | 1.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 1.9 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.2 | 0.2 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.2 | 0.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.2 | 0.7 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
0.2 | 0.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 0.7 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
0.2 | 0.2 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.2 | 0.5 | GO:0031223 | auditory behavior(GO:0031223) |
0.2 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 0.2 | GO:0002208 | somatic recombination of immunoglobulin genes involved in immune response(GO:0002204) somatic diversification of immunoglobulins involved in immune response(GO:0002208) isotype switching(GO:0045190) |
0.2 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.9 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.2 | 0.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 1.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 1.6 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.7 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.2 | 0.5 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.2 | 0.2 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.2 | 0.5 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.2 | 0.7 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.2 | 1.2 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.2 | 0.7 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.2 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.9 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
0.2 | 0.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.5 | GO:0036292 | DNA rewinding(GO:0036292) |
0.2 | 0.9 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 | 6.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.2 | 2.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.9 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.2 | 2.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.2 | 2.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 1.1 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.2 | 0.2 | GO:0061217 | positive regulation of mesonephros development(GO:0061213) regulation of mesonephros development(GO:0061217) |
0.2 | 0.7 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.2 | 3.0 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 0.2 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.2 | 0.7 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.5 | GO:0036166 | phenotypic switching(GO:0036166) |
0.2 | 2.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 5.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 13.3 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.2 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 0.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.9 | GO:0060709 | glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
0.2 | 1.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.2 | 0.7 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.2 | 3.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 0.4 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.2 | 0.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.7 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 2.7 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.2 | 4.0 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.2 | 0.2 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.2 | 2.0 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.2 | 1.3 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.2 | 1.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.9 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.2 | 1.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.2 | 0.9 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.2 | 0.2 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.2 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.7 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.2 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 11.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 1.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 3.5 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.4 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.2 | 1.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 3.5 | GO:0001893 | maternal placenta development(GO:0001893) |
0.2 | 0.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 1.3 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.2 | 1.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.9 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 1.3 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.2 | 0.6 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
0.2 | 7.7 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.2 | 0.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 0.4 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.2 | 1.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.2 | 0.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 3.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.2 | 0.6 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 0.4 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 1.5 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.2 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.2 | 1.9 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 1.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.4 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 0.2 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
0.2 | 0.6 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.2 | 1.3 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 4.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 0.2 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.2 | 1.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 0.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 0.4 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 2.1 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 0.6 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.2 | 0.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.2 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.2 | 2.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 1.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.6 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.2 | 0.8 | GO:0072683 | T cell extravasation(GO:0072683) |
0.2 | 0.2 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.2 | 0.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.2 | 0.6 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.2 | 2.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 3.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.2 | 1.8 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.2 | GO:0010360 | regulation of anion channel activity(GO:0010359) negative regulation of anion channel activity(GO:0010360) |
0.2 | 2.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 3.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.2 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 8.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 1.2 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.2 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.4 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.2 | 0.4 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.2 | 0.4 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.2 | 0.8 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.2 | 2.6 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.2 | 0.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 0.2 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.2 | 2.6 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.2 | 0.6 | GO:0086067 | AV node cell to bundle of His cell communication(GO:0086067) |
0.2 | 4.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.2 | 0.8 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) fatty-acyl-CoA catabolic process(GO:0036115) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.2 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 0.6 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.2 | 0.2 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.2 | 0.8 | GO:1903317 | regulation of protein maturation(GO:1903317) |
0.2 | 0.8 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 0.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 1.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.2 | 3.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 1.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 0.4 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.2 | 0.8 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.2 | 0.4 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.2 | 0.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.6 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 4.7 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.2 | 0.2 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
0.2 | 0.4 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 2.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 1.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.2 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.2 | 2.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 0.8 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.2 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.4 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.2 | 1.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 0.4 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.2 | 0.6 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.2 | 0.2 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.2 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.8 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.2 | 0.6 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 0.6 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.2 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.2 | 0.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 0.6 | GO:0035547 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
0.2 | 2.4 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.2 | 0.7 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.2 | 0.6 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.2 | 0.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.2 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.2 | GO:0072143 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.2 | 0.6 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.2 | 0.7 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 0.2 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.2 | 0.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.2 | GO:0044241 | lipid digestion(GO:0044241) |
0.2 | 0.4 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.2 | 0.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 1.3 | GO:0035094 | response to nicotine(GO:0035094) |
0.2 | 0.4 | GO:0048368 | paraxial mesoderm development(GO:0048339) lateral mesoderm development(GO:0048368) |
0.2 | 0.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 1.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.7 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.2 | 0.2 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.2 | 0.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 1.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 2.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 1.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 1.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 1.4 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.2 | 0.2 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
0.2 | 0.4 | GO:1902224 | cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
0.2 | 0.7 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 0.5 | GO:0060416 | response to growth hormone(GO:0060416) |
0.2 | 0.2 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.2 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.4 | GO:0007398 | ectoderm development(GO:0007398) |
0.2 | 0.7 | GO:0006788 | heme oxidation(GO:0006788) |
0.2 | 0.7 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.2 | 0.2 | GO:0035553 | oxidative single-stranded RNA demethylation(GO:0035553) oxidative demethylation(GO:0070989) |
0.2 | 0.9 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 1.9 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 0.7 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.2 | 0.3 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.2 | 0.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.2 | 0.2 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.2 | 1.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 2.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.2 | 2.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.2 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 0.9 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 0.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 1.0 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.2 | 2.5 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.2 | 1.2 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) synaptic vesicle budding(GO:0070142) |
0.2 | 0.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 5.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.5 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.2 | GO:2000822 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
0.2 | 0.8 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.5 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.2 | 1.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 0.7 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.2 | 2.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.2 | 1.0 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.2 | 0.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.7 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.2 | 1.0 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.2 | 1.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.5 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 0.5 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.2 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.2 | 3.0 | GO:0022900 | electron transport chain(GO:0022900) |
0.2 | 1.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.2 | 0.2 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 1.3 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.2 | 0.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 0.2 | GO:0044805 | late nucleophagy(GO:0044805) |
0.2 | 3.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 1.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.2 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.2 | 0.2 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.3 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.2 | 0.5 | GO:0071035 | nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.2 | 0.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.2 | 0.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 0.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.5 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.2 | 0.5 | GO:0030421 | defecation(GO:0030421) |
0.2 | 1.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 1.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.5 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.2 | 2.2 | GO:0090662 | ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.2 | 0.9 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 1.3 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.2 | 0.3 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 0.2 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.2 | 0.6 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.3 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.2 | 0.2 | GO:0019046 | release from viral latency(GO:0019046) |
0.2 | 1.7 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.2 | 0.2 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.2 | 3.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 1.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.2 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.2 | 2.2 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.2 | 0.8 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.2 | 0.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.3 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 0.2 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.2 | 0.5 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 1.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.8 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 0.2 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.2 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.6 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 1.3 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.1 | 0.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.4 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 1.6 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 5.6 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.1 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 1.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.4 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.1 | 0.6 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
0.1 | 0.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 1.6 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 1.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.1 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.1 | 5.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 2.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.3 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 0.3 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 1.3 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 0.3 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.7 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 2.5 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 0.3 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.1 | 0.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.3 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 0.3 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.1 | 1.7 | GO:1904377 | positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.1 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 1.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 1.8 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 1.0 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.1 | GO:0070344 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.1 | 0.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 1.8 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.5 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.3 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 1.3 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
0.1 | 0.9 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 0.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 2.3 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 2.0 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.3 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.1 | 0.4 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 1.7 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.7 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.4 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 1.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.3 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 5.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 1.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 2.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 1.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.8 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.4 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 1.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 1.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.4 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.1 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.1 | 0.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 1.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 1.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 2.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.7 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 1.5 | GO:0044319 | wound healing, spreading of cells(GO:0044319) epiboly involved in wound healing(GO:0090505) |
0.1 | 0.9 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 3.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.2 | GO:0019400 | glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
0.1 | 0.4 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 0.4 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.7 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.1 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.2 | GO:0046370 | fructose biosynthetic process(GO:0046370) |
0.1 | 0.9 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 1.3 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 1.0 | GO:0030431 | sleep(GO:0030431) |
0.1 | 2.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.2 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.6 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.1 | 0.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 4.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.7 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 1.5 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
0.1 | 1.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 1.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.2 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 1.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.1 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.1 | 0.9 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.7 | GO:0009262 | deoxyribonucleotide metabolic process(GO:0009262) |
0.1 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.7 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 1.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.3 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.2 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.1 | 0.3 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.1 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 1.9 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 2.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.2 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.1 | 0.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.2 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0044346 | fibroblast apoptotic process(GO:0044346) regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 0.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 0.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.4 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.5 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.1 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 4.1 | GO:0045333 | cellular respiration(GO:0045333) |
0.1 | 0.3 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.3 | GO:0003345 | proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
0.1 | 1.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.3 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.1 | 0.8 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.5 | GO:0031579 | membrane raft organization(GO:0031579) |
0.1 | 0.6 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 5.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.2 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.1 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 2.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.9 | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity(GO:0001912) |
0.1 | 1.7 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.1 | 0.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.1 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.1 | 0.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.6 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.1 | 0.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.9 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 1.3 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.3 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 1.2 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 1.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.1 | 0.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.1 | 1.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.1 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.4 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.1 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.1 | 0.1 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.1 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.3 | GO:0016598 | protein arginylation(GO:0016598) |
0.1 | 1.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.4 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 1.5 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.1 | 0.1 | GO:0035937 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
0.1 | 0.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.1 | 0.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.1 | 1.0 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.7 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.6 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.3 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.1 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.2 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 2.0 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.5 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.3 | GO:0060051 | negative regulation of protein ADP-ribosylation(GO:0010836) negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.3 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
0.1 | 0.2 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.2 | GO:1903533 | regulation of protein targeting(GO:1903533) |
0.1 | 0.4 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.2 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.2 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.2 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.1 | 0.2 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
0.1 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.2 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 1.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.2 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 0.2 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.1 | 0.3 | GO:0060690 | epithelial cell differentiation involved in salivary gland development(GO:0060690) |
0.1 | 0.2 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 1.1 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.3 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.3 | GO:0001547 | antral ovarian follicle growth(GO:0001547) ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.1 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.2 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
0.1 | 0.2 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.1 | 0.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
0.1 | 0.4 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
0.1 | 4.0 | GO:1903214 | regulation of protein targeting to mitochondrion(GO:1903214) |
0.1 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:1901727 | positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.5 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.1 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.1 | 0.5 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.7 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.4 | GO:0042267 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 0.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 2.8 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 1.4 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.4 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.1 | 0.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.2 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.1 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 1.2 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.1 | 0.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 1.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.5 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 1.8 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 0.3 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.2 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
0.1 | 0.3 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.1 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.1 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.5 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.1 | GO:1990743 | protein sialylation(GO:1990743) |
0.1 | 0.1 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.1 | 0.1 | GO:1902474 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 1.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.4 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.9 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.1 | 0.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 3.9 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.1 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.2 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.4 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.4 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.3 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.1 | 0.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.8 | GO:0031638 | zymogen activation(GO:0031638) |
0.1 | 0.4 | GO:0015838 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.1 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.6 | GO:0052548 | regulation of endopeptidase activity(GO:0052548) |
0.1 | 0.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.1 | 0.2 | GO:0098869 | cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.1 | 1.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.1 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.1 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.2 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.1 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 0.2 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.1 | 0.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.1 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.7 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.3 | GO:0050679 | positive regulation of epithelial cell proliferation(GO:0050679) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.7 | GO:1902806 | regulation of cell cycle G1/S phase transition(GO:1902806) |
0.0 | 0.1 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.1 | GO:0090646 | mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA processing(GO:0090646) |
0.0 | 0.1 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 1.7 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.8 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.0 | 0.0 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.5 | GO:1904591 | positive regulation of protein import(GO:1904591) |
0.0 | 0.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.9 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 2.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.1 | GO:0033865 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.0 | 0.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.2 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.0 | 0.1 | GO:0001827 | inner cell mass cell differentiation(GO:0001826) inner cell mass cell fate commitment(GO:0001827) |
0.0 | 0.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.0 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.0 | 0.1 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.0 | 0.4 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.0 | 0.1 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 1.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.3 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.0 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 1.0 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.0 | 0.2 | GO:0043482 | pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
0.0 | 0.2 | GO:0034312 | diol biosynthetic process(GO:0034312) |
0.0 | 0.0 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.0 | 0.2 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.0 | GO:0002606 | dendritic cell antigen processing and presentation(GO:0002468) positive regulation of antigen processing and presentation(GO:0002579) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.0 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.5 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.0 | 0.1 | GO:1990839 | response to endothelin(GO:1990839) |
0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.3 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.0 | 0.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.0 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.0 | 0.3 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.1 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
0.0 | 0.1 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.0 | 0.3 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.0 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.0 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.0 | 0.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.0 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.0 | 0.1 | GO:0042092 | type 2 immune response(GO:0042092) |
0.0 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) |
0.0 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.2 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.0 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.0 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.0 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0042401 | amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
0.0 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.1 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.0 | 0.7 | GO:0006195 | purine nucleotide catabolic process(GO:0006195) |
0.0 | 0.1 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.0 | 0.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.1 | GO:0098877 | neurotransmitter receptor transport to plasma membrane(GO:0098877) |
0.0 | 0.0 | GO:0061511 | centriole elongation(GO:0061511) |
0.0 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.0 | 0.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.0 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.0 | 0.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.2 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.2 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.2 | GO:0043486 | histone exchange(GO:0043486) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:0080184 | response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
0.0 | 0.3 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.0 | 0.1 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.0 | 0.0 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.0 | 0.1 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.0 | GO:0021678 | third ventricle development(GO:0021678) |
0.0 | 0.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.9 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 0.4 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) sensory perception of bitter taste(GO:0050913) |
0.0 | 0.1 | GO:0045123 | cellular extravasation(GO:0045123) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.0 | 0.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.0 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.0 | 0.1 | GO:0002891 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
0.0 | 0.1 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.0 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.0 | GO:0051905 | establishment of pigment granule localization(GO:0051905) |
0.0 | 0.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.6 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.0 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.0 | 0.0 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 0.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.0 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.1 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.0 | 0.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.0 | 0.0 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
0.0 | 0.2 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.0 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 6.9 | GO:0060187 | cell pole(GO:0060187) |
1.2 | 1.2 | GO:1990635 | proximal dendrite(GO:1990635) |
1.1 | 3.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.0 | 3.0 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.9 | 2.6 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.9 | 5.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.8 | 2.4 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.8 | 5.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.8 | 5.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.8 | 3.0 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.7 | 2.9 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.7 | 2.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.7 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.7 | 4.9 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.7 | 5.5 | GO:0097433 | dense body(GO:0097433) |
0.7 | 2.1 | GO:0099573 | glutamatergic postsynaptic density(GO:0099573) |
0.7 | 2.0 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.7 | 1.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.7 | 2.0 | GO:0032590 | dendrite membrane(GO:0032590) |
0.7 | 0.7 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.7 | 4.6 | GO:0001740 | Barr body(GO:0001740) |
0.6 | 1.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.6 | 1.9 | GO:0036125 | mitochondrial fatty acid beta-oxidation multienzyme complex(GO:0016507) fatty acid beta-oxidation multienzyme complex(GO:0036125) |
0.6 | 3.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.6 | 1.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.6 | 1.9 | GO:0032280 | symmetric synapse(GO:0032280) |
0.6 | 1.9 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.6 | 3.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.6 | 1.8 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.6 | 2.4 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.6 | 0.6 | GO:0032982 | myosin filament(GO:0032982) |
0.6 | 2.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 1.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.5 | 2.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 6.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.5 | 4.2 | GO:0044298 | cell body membrane(GO:0044298) |
0.5 | 1.6 | GO:0071914 | prominosome(GO:0071914) |
0.5 | 1.0 | GO:0014802 | terminal cisterna(GO:0014802) |
0.5 | 3.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.5 | 6.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.5 | 1.5 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.5 | 3.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.5 | 1.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 2.0 | GO:1990032 | parallel fiber(GO:1990032) |
0.5 | 6.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.5 | 4.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.5 | 1.4 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.5 | 0.5 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.5 | 1.9 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.5 | 1.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.5 | 1.4 | GO:0044299 | C-fiber(GO:0044299) |
0.5 | 3.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.5 | 1.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.5 | 1.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.5 | 5.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.5 | 1.4 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.5 | 7.8 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 5.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.5 | 0.9 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.4 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 2.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.4 | 3.1 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 4.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.4 | 6.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.4 | 14.6 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.4 | 4.7 | GO:0032426 | stereocilium tip(GO:0032426) |
0.4 | 1.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 2.5 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 1.7 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.4 | 0.4 | GO:0032437 | cuticular plate(GO:0032437) |
0.4 | 2.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 1.6 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 0.8 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.4 | 2.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 3.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.4 | 0.8 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.4 | 2.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.4 | 1.6 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.4 | 2.4 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.4 | 1.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.4 | 4.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.4 | 1.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 1.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 3.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.4 | 1.2 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.4 | 0.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.4 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 3.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.4 | 1.1 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.4 | 2.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.4 | 26.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 1.5 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.4 | 3.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 1.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 5.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.4 | 2.9 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.4 | 0.7 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.4 | 1.1 | GO:0018444 | translation release factor complex(GO:0018444) |
0.4 | 2.9 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.4 | 2.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 2.2 | GO:0044308 | axonal spine(GO:0044308) |
0.4 | 0.4 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.4 | 1.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.4 | 2.9 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.4 | 7.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 0.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.4 | 1.1 | GO:0000801 | central element(GO:0000801) |
0.4 | 20.8 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.4 | 0.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 17.6 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.4 | 6.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.4 | 3.5 | GO:0046930 | pore complex(GO:0046930) |
0.4 | 4.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 1.0 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.3 | 1.0 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.3 | 1.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.3 | 1.0 | GO:1990047 | spindle matrix(GO:1990047) |
0.3 | 5.9 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 3.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.3 | 3.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.3 | 1.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 1.7 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 0.3 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.3 | 1.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 0.3 | GO:0000785 | chromatin(GO:0000785) |
0.3 | 1.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 1.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 1.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 1.0 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.3 | 1.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 1.6 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.3 | 0.9 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.3 | 1.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.3 | 1.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 0.3 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.3 | 0.6 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.3 | 0.9 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.3 | 2.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 3.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 0.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 2.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 0.9 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.3 | 2.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 1.2 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.3 | 3.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 0.9 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 1.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 1.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 3.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 3.6 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.3 | 2.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 2.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 0.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 1.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 1.2 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.3 | 3.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.3 | 2.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 0.9 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 2.0 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.3 | 4.6 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.3 | 1.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 2.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.3 | 0.6 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.3 | 1.7 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 3.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 1.1 | GO:1903349 | omegasome membrane(GO:1903349) |
0.3 | 2.8 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.3 | 2.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 2.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 2.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.3 | 13.4 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.3 | 0.6 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 0.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 0.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 2.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.3 | 4.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 1.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 0.8 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.3 | 1.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 4.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 0.5 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.3 | 0.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 5.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.3 | 0.8 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.3 | 5.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 4.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.3 | 1.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 1.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 1.8 | GO:0016459 | myosin complex(GO:0016459) |
0.3 | 4.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.3 | 3.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 0.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 2.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 2.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 0.8 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.3 | 1.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.7 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 2.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 1.2 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 11.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 3.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.5 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.2 | 1.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 1.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 1.2 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 4.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 1.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 1.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.2 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 1.9 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 1.6 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 0.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.2 | 3.3 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 0.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 3.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.7 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.2 | 5.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 2.1 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 1.6 | GO:0045177 | apical part of cell(GO:0045177) |
0.2 | 0.9 | GO:0097447 | dendritic tree(GO:0097447) |
0.2 | 1.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 0.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 1.8 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 0.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 2.9 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 1.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 3.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 1.8 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.4 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 2.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 1.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 3.3 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 0.9 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 0.7 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.2 | 1.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 2.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 2.2 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 2.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 5.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 3.8 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.2 | 0.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 1.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 2.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 1.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 0.8 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 1.5 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 1.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 1.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.8 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 1.6 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 1.0 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.2 | 0.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 1.4 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 2.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 1.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 0.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 0.6 | GO:0099631 | postsynaptic endocytic zone cytoplasmic component(GO:0099631) |
0.2 | 0.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 1.6 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 0.4 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.2 | GO:0042611 | MHC protein complex(GO:0042611) |
0.2 | 2.5 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 1.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 0.6 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 0.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 1.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 2.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 1.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 0.7 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 0.9 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 7.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 1.6 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 0.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 1.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 0.5 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 1.2 | GO:0036464 | cytoplasmic ribonucleoprotein granule(GO:0036464) |
0.2 | 0.5 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.2 | 4.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 1.2 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.2 | 2.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 2.4 | GO:0043235 | receptor complex(GO:0043235) |
0.2 | 1.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 2.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 0.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 3.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 0.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 2.0 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.2 | 1.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 0.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 2.3 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 3.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 6.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 0.3 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 0.5 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.2 | 9.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 2.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 1.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.2 | 1.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 0.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 0.9 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 0.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.2 | 0.8 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 1.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 1.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.9 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.2 | 0.8 | GO:0070826 | paraferritin complex(GO:0070826) |
0.2 | 0.6 | GO:0008623 | CHRAC(GO:0008623) |
0.1 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 1.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 1.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 1.9 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 11.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 2.2 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.3 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
0.1 | 0.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 1.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 2.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.4 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 12.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.7 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 2.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) replisome(GO:0030894) nuclear replisome(GO:0043601) |
0.1 | 0.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 3.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 8.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 2.1 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.7 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 1.9 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.1 | GO:0030141 | secretory granule(GO:0030141) |
0.1 | 0.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 2.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 1.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 1.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 4.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 1.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 1.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 3.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 34.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 1.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 1.2 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.7 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.1 | 1.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.5 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.1 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 4.3 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 1.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 2.1 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 1.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 1.0 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 2.9 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 1.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 1.4 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 3.6 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 8.9 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.3 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 4.1 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 1.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.6 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 1.6 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 7.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.4 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 4.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.1 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.1 | 2.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 1.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.2 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.3 | GO:0031533 | mRNA cap methyltransferase complex(GO:0031533) |
0.1 | 0.4 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 1.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 1.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 3.3 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 3.0 | GO:0016020 | membrane(GO:0016020) |
0.1 | 2.1 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 1.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 0.2 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 1.8 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 1.8 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.1 | 1.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 97.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.1 | 0.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 1.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 1.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 2.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.7 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.1 | GO:0030135 | coated vesicle(GO:0030135) |
0.1 | 0.1 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.1 | 0.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.3 | GO:0001940 | female pronucleus(GO:0001939) male pronucleus(GO:0001940) |
0.1 | 0.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.6 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 117.1 | GO:0043230 | extracellular organelle(GO:0043230) |
0.1 | 0.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 2.0 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.7 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.2 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 0.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.6 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.2 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.1 | 0.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 1.3 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 2.0 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 3.8 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 6.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.2 | GO:0005818 | aster(GO:0005818) |
0.0 | 28.6 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.6 | GO:0030684 | preribosome(GO:0030684) |
0.0 | 0.2 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.0 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 1.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.4 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.6 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.5 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 59.6 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.3 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.4 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 8.9 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.9 | 9.4 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
1.8 | 16.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.7 | 6.9 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
1.6 | 4.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.6 | 6.4 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
1.5 | 4.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.4 | 1.4 | GO:0005110 | frizzled-2 binding(GO:0005110) |
1.4 | 5.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
1.3 | 5.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.3 | 6.3 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
1.2 | 6.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.2 | 4.9 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
1.2 | 5.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.2 | 5.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.2 | 5.8 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
1.1 | 3.4 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
1.1 | 5.7 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
1.0 | 4.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.0 | 12.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.9 | 5.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.9 | 2.7 | GO:0051379 | epinephrine binding(GO:0051379) |
0.9 | 2.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.9 | 5.3 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.9 | 2.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.9 | 5.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.8 | 2.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.8 | 0.8 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.8 | 2.5 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.8 | 2.4 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
0.8 | 2.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.8 | 3.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.8 | 4.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.8 | 5.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.8 | 2.3 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.8 | 2.3 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.8 | 5.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.8 | 2.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.8 | 4.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.8 | 4.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.8 | 2.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.7 | 2.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.7 | 2.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.7 | 7.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.7 | 2.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.7 | 2.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.7 | 6.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.6 | 1.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.6 | 1.9 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.6 | 6.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.6 | 2.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.6 | 3.1 | GO:0070330 | aromatase activity(GO:0070330) |
0.6 | 1.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.6 | 0.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 5.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 3.7 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.6 | 3.1 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.6 | 1.9 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.6 | 2.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.6 | 7.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 1.8 | GO:0004335 | galactokinase activity(GO:0004335) |
0.6 | 1.8 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.6 | 1.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.6 | 2.4 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.6 | 8.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.6 | 1.8 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.6 | 1.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.6 | 8.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 14.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.6 | 3.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 1.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.6 | 2.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.6 | 1.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.6 | 3.3 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.6 | 7.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 2.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.5 | 0.5 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.5 | 6.0 | GO:0048185 | activin binding(GO:0048185) |
0.5 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.5 | 4.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.5 | 2.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.5 | 8.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 2.7 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.5 | 2.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 1.6 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.5 | 3.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 3.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.5 | 1.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.5 | 1.1 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 2.6 | GO:0000339 | RNA cap binding(GO:0000339) |
0.5 | 0.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.5 | 0.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.5 | 1.5 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.5 | 6.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.5 | 2.0 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.5 | 2.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.5 | 23.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.5 | 4.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 1.5 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.5 | 11.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.5 | 6.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.5 | 1.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.5 | 2.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.5 | 1.5 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.5 | 2.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.5 | 1.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.5 | 1.9 | GO:0003681 | bent DNA binding(GO:0003681) |
0.5 | 1.4 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
0.5 | 2.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 1.4 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.5 | 1.4 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.5 | 1.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.5 | 0.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 2.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 6.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 0.5 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.5 | 7.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.5 | 9.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.5 | 0.9 | GO:0043559 | insulin binding(GO:0043559) |
0.5 | 4.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.5 | 0.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.5 | 1.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 0.9 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.4 | 0.9 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.4 | 0.9 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 1.8 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.4 | 13.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 3.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 1.3 | GO:0051870 | methotrexate binding(GO:0051870) |
0.4 | 1.3 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.4 | 1.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 1.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 5.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.4 | 15.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.4 | 3.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 1.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.4 | 3.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 3.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.4 | 2.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 1.7 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.4 | 5.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.4 | 3.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.4 | 2.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.4 | 2.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.4 | 1.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.4 | 1.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.4 | 2.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.4 | 2.0 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.4 | 3.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 6.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 2.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 70.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.4 | 2.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 5.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.4 | 1.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.4 | 0.4 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.4 | 2.0 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.4 | 1.6 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.4 | 1.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 1.6 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.4 | 1.2 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.4 | 2.4 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.4 | 4.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 2.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.4 | 1.2 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
0.4 | 1.6 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.4 | 9.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.4 | 0.4 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.4 | 1.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 3.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.4 | 1.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.4 | 1.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.4 | 1.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 1.5 | GO:0015266 | protein channel activity(GO:0015266) |
0.4 | 1.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.4 | 1.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.4 | 11.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 1.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.4 | 2.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.4 | 0.7 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 1.5 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.4 | 4.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 3.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 1.8 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.4 | 12.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 1.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 1.1 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.4 | 0.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 1.0 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.3 | 1.0 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.3 | 1.0 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.3 | 2.8 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 2.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.3 | 3.8 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 1.0 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.3 | 1.0 | GO:0036004 | GAF domain binding(GO:0036004) |
0.3 | 2.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 1.0 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.3 | 1.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 1.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 2.7 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 3.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 2.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 1.6 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.3 | 3.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 2.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 1.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.3 | 1.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.3 | 1.3 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.3 | 2.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 1.6 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 2.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.3 | 1.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 0.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.3 | 1.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.3 | 5.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 1.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 0.6 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.3 | 0.9 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 15.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 2.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.3 | 0.9 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.3 | 1.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.3 | 0.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 1.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.3 | 2.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 6.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 3.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 3.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.3 | 2.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 4.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.3 | 1.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 0.9 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.3 | 3.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 13.9 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.3 | 1.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 0.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.3 | 0.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 1.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.3 | 1.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 3.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 1.4 | GO:0016594 | glycine binding(GO:0016594) |
0.3 | 0.9 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 3.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 1.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.3 | 6.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 6.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 1.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 0.8 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.3 | 1.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 1.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.3 | 1.4 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.3 | 3.6 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.9 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 1.4 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 4.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 0.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 0.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 1.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.3 | 0.8 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.3 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 1.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 3.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 0.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 1.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 3.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 3.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 1.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 2.9 | GO:0045182 | translation regulator activity(GO:0045182) |
0.3 | 0.8 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.3 | 5.6 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 3.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.3 | 1.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 1.1 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.3 | 0.8 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.3 | 0.5 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 0.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.3 | 0.3 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.3 | 2.1 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.3 | 1.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 2.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 0.8 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.3 | 2.0 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 1.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.3 | 0.5 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.3 | 1.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.3 | 4.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 0.8 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.3 | 1.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 2.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 1.0 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.2 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 1.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 3.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 1.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 1.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.2 | 1.7 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 3.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 1.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 1.9 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 3.4 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 1.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.2 | 1.0 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 7.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 7.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 2.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 2.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 1.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 4.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 2.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 0.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 0.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.2 | 2.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 2.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.2 | 0.9 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.2 | 0.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.7 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 8.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 0.9 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.2 | 0.9 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 2.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 8.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 0.9 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 1.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 2.7 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.7 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.2 | 1.8 | GO:0070990 | snRNP binding(GO:0070990) |
0.2 | 1.1 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.2 | 12.9 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 0.5 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 2.3 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.2 | 4.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 1.3 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.2 | 2.9 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 1.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 0.9 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.2 | 1.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 0.6 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.2 | 1.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 1.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 1.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.4 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.2 | 0.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.6 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.2 | 1.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.2 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.2 | 0.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.4 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 0.6 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 2.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 1.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 1.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.8 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 0.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 0.6 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.2 | 0.6 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 0.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 0.6 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.2 | 1.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 0.4 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.2 | 0.8 | GO:0051861 | glycolipid binding(GO:0051861) |
0.2 | 0.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 1.2 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.2 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.4 | GO:0031403 | lithium ion binding(GO:0031403) vitamin B6 binding(GO:0070279) |
0.2 | 1.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 0.6 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.2 | 2.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 0.8 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.2 | 1.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 1.0 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.2 | 10.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 11.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 1.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 1.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 5.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 0.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 3.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.2 | GO:0019864 | immunoglobulin receptor activity(GO:0019763) IgG binding(GO:0019864) |
0.2 | 0.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.2 | 0.2 | GO:0004954 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
0.2 | 0.4 | GO:0019962 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
0.2 | 0.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 0.7 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 2.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 1.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 1.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.6 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
0.2 | 2.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 5.7 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 2.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.2 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.2 | 0.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 1.6 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 0.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 0.7 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.5 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.7 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.2 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 0.5 | GO:0043532 | angiostatin binding(GO:0043532) |
0.2 | 1.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 0.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 1.2 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.5 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.2 | 0.5 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 0.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 2.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.7 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 0.8 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.2 | GO:0070404 | NADH binding(GO:0070404) |
0.2 | 2.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 0.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 1.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 0.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 0.7 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.2 | 0.5 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.2 | 2.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 3.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 0.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.2 | 1.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.8 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
0.2 | 0.3 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.2 | 1.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 1.7 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 4.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 5.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.5 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
0.2 | 0.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 1.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 10.7 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.2 | 0.9 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.2 | 2.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 0.9 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.2 | 0.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 6.1 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.3 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.2 | 0.5 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.2 | 0.3 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 4.9 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.4 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 1.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 1.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 7.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 3.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 1.8 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 1.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.3 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 1.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 29.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 1.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.4 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.1 | 1.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.6 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.1 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.3 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 14.3 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.7 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 1.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 2.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 1.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 4.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.3 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 1.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 2.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 1.5 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.1 | 0.9 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.5 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 0.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 1.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 3.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.4 | GO:1901338 | dopamine binding(GO:0035240) catecholamine binding(GO:1901338) |
0.1 | 1.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 1.8 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.4 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.1 | 0.4 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.1 | 0.5 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.1 | 7.5 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 1.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 2.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.2 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
0.1 | 2.0 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.1 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.8 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 1.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 5.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 1.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.9 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 1.3 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 1.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.5 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.1 | 0.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 1.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 8.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 1.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.3 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 0.8 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 0.7 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.3 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 1.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 1.0 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 1.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 3.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.3 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.3 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.1 | 1.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 1.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.2 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.1 | 0.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 1.0 | GO:0004691 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 3.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.5 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.1 | 0.2 | GO:0032356 | oxidized DNA binding(GO:0032356) |
0.1 | 0.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 1.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 1.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.5 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.1 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.3 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
0.1 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.5 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.3 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.1 | 0.4 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.1 | 3.4 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.4 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.1 | 0.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 1.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.3 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.3 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 1.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 1.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.3 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.1 | 1.5 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 1.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 7.0 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.2 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.1 | 0.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 0.9 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.2 | GO:0016174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) NAD(P)H oxidase activity(GO:0016174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.3 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 2.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.7 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.2 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 1.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
0.1 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 0.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.2 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.1 | 0.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.3 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.2 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.1 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 2.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 1.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.6 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 2.8 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 1.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.2 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.1 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 1.7 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.2 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.1 | 0.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 3.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.9 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 4.5 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 1.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.4 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.0 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.1 | GO:0017084 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
0.0 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.0 | 0.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 1.4 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 2.1 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.0 | GO:0070538 | oleic acid binding(GO:0070538) |
0.0 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 1.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.8 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.0 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.0 | 2.0 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.0 | 0.2 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 1.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 0.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.5 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.8 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.6 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.0 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.0 | 0.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
0.0 | 0.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.0 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.0 | 0.1 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 0.9 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.6 | 17.8 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
0.6 | 0.6 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 1.0 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
0.5 | 1.9 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
0.5 | 0.5 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
0.5 | 7.2 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 16.1 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 0.4 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 0.8 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.4 | 10.7 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 16.0 | PID_ALK1_PATHWAY | ALK1 signaling events |
0.4 | 0.4 | PID_NFKAPPAB_ATYPICAL_PATHWAY | Atypical NF-kappaB pathway |
0.3 | 0.3 | PID_ALK2_PATHWAY | ALK2 signaling events |
0.3 | 15.3 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 8.0 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 5.5 | PID_LYMPH_ANGIOGENESIS_PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 11.1 | PID_IL2_STAT5_PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 11.7 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
0.3 | 0.9 | PID_GMCSF_PATHWAY | GMCSF-mediated signaling events |
0.3 | 0.3 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 4.2 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 6.8 | SA_TRKA_RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 1.5 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
0.2 | 0.5 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 2.0 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 2.0 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 4.6 | PID_IL2_1PATHWAY | IL2-mediated signaling events |
0.2 | 2.4 | PID_THROMBIN_PAR4_PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 3.3 | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 2.7 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
0.2 | 8.2 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 7.3 | PID_AURORA_A_PATHWAY | Aurora A signaling |
0.2 | 0.7 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 3.1 | PID_IL3_PATHWAY | IL3-mediated signaling events |
0.2 | 1.1 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 3.1 | PID_IL27_PATHWAY | IL27-mediated signaling events |
0.2 | 8.7 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
0.2 | 6.1 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 2.8 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
0.2 | 0.6 | PID_EPO_PATHWAY | EPO signaling pathway |
0.2 | 2.4 | PID_TRAIL_PATHWAY | TRAIL signaling pathway |
0.2 | 1.0 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 11.5 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
0.2 | 1.0 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 9.9 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 6.1 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 0.9 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
0.2 | 18.8 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 3.3 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 0.5 | PID_IFNG_PATHWAY | IFN-gamma pathway |
0.2 | 4.0 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
0.2 | 0.2 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
0.2 | 4.9 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 3.0 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 5.6 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 12.1 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 10.0 | PID_P73PATHWAY | p73 transcription factor network |
0.2 | 0.3 | PID_TCPTP_PATHWAY | Signaling events mediated by TCPTP |
0.2 | 12.7 | WNT_SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 0.3 | PID_ENDOTHELIN_PATHWAY | Endothelins |
0.2 | 3.7 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 18.8 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 8.0 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
0.1 | 4.6 | PID_BMP_PATHWAY | BMP receptor signaling |
0.1 | 3.4 | PID_CXCR3_PATHWAY | CXCR3-mediated signaling events |
0.1 | 3.2 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.2 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 1.8 | PID_EPHB_FWD_PATHWAY | EPHB forward signaling |
0.1 | 4.2 | PID_INSULIN_PATHWAY | Insulin Pathway |
0.1 | 5.3 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
0.1 | 4.0 | PID_ARF_3PATHWAY | Arf1 pathway |
0.1 | 2.7 | PID_FGF_PATHWAY | FGF signaling pathway |
0.1 | 4.3 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.1 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
0.1 | 4.3 | PID_ATR_PATHWAY | ATR signaling pathway |
0.1 | 0.4 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 4.5 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
0.1 | 3.7 | PID_TRKR_PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 4.8 | PID_MYC_REPRESS_PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.0 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.1 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.9 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
0.1 | 0.2 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 4.4 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.5 | PID_TGFBR_PATHWAY | TGF-beta receptor signaling |
0.1 | 0.1 | PID_IGF1_PATHWAY | IGF1 pathway |
0.1 | 4.5 | PID_NOTCH_PATHWAY | Notch signaling pathway |
0.1 | 0.9 | PID_IL1_PATHWAY | IL1-mediated signaling events |
0.1 | 1.5 | PID_FOXO_PATHWAY | FoxO family signaling |
0.1 | 1.5 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 2.9 | PID_E2F_PATHWAY | E2F transcription factor network |
0.1 | 5.3 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
0.1 | 4.2 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 2.6 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.1 | PID_AR_NONGENOMIC_PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.4 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
0.1 | 0.2 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.7 | PID_INTEGRIN1_PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.8 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.7 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 3.2 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 3.5 | PID_BETA_CATENIN_NUC_PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.1 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
0.1 | 0.7 | PID_ERBB1_DOWNSTREAM_PATHWAY | ErbB1 downstream signaling |
0.1 | 0.5 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
0.1 | 2.1 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.1 | ST_INTERLEUKIN_4_PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.7 | PID_LYSOPHOSPHOLIPID_PATHWAY | LPA receptor mediated events |
0.1 | 0.2 | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.8 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
0.1 | 0.1 | ST_JAK_STAT_PATHWAY | Jak-STAT Pathway |
0.1 | 1.6 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
0.0 | 0.3 | ST_GA12_PATHWAY | G alpha 12 Pathway |
0.0 | 0.1 | ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY | PI3K Pathway |
0.0 | 0.1 | ST_INTERFERON_GAMMA_PATHWAY | Interferon gamma pathway. |
0.0 | 0.2 | PID_TCR_CALCIUM_PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.3 | PID_AVB3_INTEGRIN_PATHWAY | Integrins in angiogenesis |
0.0 | 0.9 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.5 | PID_FCER1_PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.0 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
0.0 | 0.2 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.1 | PID_ER_NONGENOMIC_PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.8 | PID_RAS_PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | PID_BARD1_PATHWAY | BARD1 signaling events |
0.0 | 0.6 | ST_MYOCYTE_AD_PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.8 | PID_AURORA_B_PATHWAY | Aurora B signaling |
0.0 | 0.3 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 3.0 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.6 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
0.0 | 0.0 | PID_REELIN_PATHWAY | Reelin signaling pathway |
0.0 | 0.2 | PID_BCR_5PATHWAY | BCR signaling pathway |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 1.1 | REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP | Genes involved in Destabilization of mRNA by KSRP |
1.0 | 1.0 | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.9 | 0.9 | REACTOME_SIGNALING_BY_FGFR3_MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.9 | 14.0 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.9 | 2.6 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.6 | 9.7 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 0.6 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 0.6 | REACTOME_GPCR_LIGAND_BINDING | Genes involved in GPCR ligand binding |
0.6 | 13.6 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.6 | 9.8 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.6 | 5.9 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.6 | 1.1 | REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.6 | 0.6 | REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.5 | 7.9 | REACTOME_RAF_MAP_KINASE_CASCADE | Genes involved in RAF/MAP kinase cascade |
0.5 | 18.3 | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.5 | 11.9 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.5 | 9.3 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.5 | 0.5 | REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.5 | 6.8 | REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.5 | 18.9 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 0.5 | REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 0.9 | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 6.0 | REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.5 | 5.6 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.5 | 4.6 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 3.1 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
0.4 | 23.3 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.4 | 15.0 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.4 | 3.7 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 20.3 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 28.3 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 2.4 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
0.4 | 4.4 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
0.4 | 24.7 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
0.4 | 4.0 | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 2.0 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 28.9 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.4 | 3.5 | REACTOME_ELONGATION_ARREST_AND_RECOVERY | Genes involved in Elongation arrest and recovery |
0.4 | 4.2 | REACTOME_ERKS_ARE_INACTIVATED | Genes involved in ERKs are inactivated |
0.4 | 6.9 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.4 | 4.2 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
0.4 | 9.8 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.4 | 1.5 | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.4 | 8.4 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
0.4 | 9.0 | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 1.7 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 11.1 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 4.2 | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 9.6 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 0.7 | REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 12.2 | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 8.1 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 14.1 | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.3 | 2.0 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 3.8 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 10.2 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
0.3 | 2.8 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 2.4 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.3 | 4.2 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 1.5 | REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 0.9 | REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_ | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 7.5 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 4.6 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 1.4 | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.3 | 2.0 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
0.3 | 10.0 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.3 | 0.8 | REACTOME_G_PROTEIN_ACTIVATION | Genes involved in G-protein activation |
0.3 | 3.4 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 4.2 | REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.3 | 7.2 | REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 1.4 | REACTOME_SIGNALING_BY_WNT | Genes involved in Signaling by Wnt |
0.3 | 4.8 | REACTOME_PHOSPHORYLATION_OF_THE_APC_C | Genes involved in Phosphorylation of the APC/C |
0.3 | 3.2 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 5.2 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 3.5 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
0.3 | 6.1 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 11.3 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 1.8 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 3.7 | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 2.0 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
0.2 | 9.2 | REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 1.7 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 1.9 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 12.8 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
0.2 | 2.6 | REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 3.1 | REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 5.8 | REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.2 | 4.7 | REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 2.3 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 3.6 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
0.2 | 0.5 | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 1.3 | REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 3.6 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 0.7 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 3.1 | REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 2.2 | REACTOME_GLOBAL_GENOMIC_NER_GG_NER | Genes involved in Global Genomic NER (GG-NER) |
0.2 | 2.4 | REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 10.7 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 2.3 | REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 0.6 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 3.4 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 14.4 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 3.6 | REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 2.1 | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 3.2 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
0.2 | 9.2 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 1.4 | REACTOME_FRS2_MEDIATED_CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 3.2 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 3.3 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 0.2 | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 2.8 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 3.5 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 4.7 | REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.2 | 16.0 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
0.2 | 3.6 | REACTOME_ACTIVATION_OF_GENES_BY_ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 3.1 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 3.6 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 7.1 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 0.7 | REACTOME_REGULATION_OF_COMPLEMENT_CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 1.5 | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 0.7 | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 1.5 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 2.3 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 1.2 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 1.7 | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 1.1 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 1.1 | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 3.5 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
0.1 | 5.1 | REACTOME_IRON_UPTAKE_AND_TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 4.5 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.8 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.2 | REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Assembly of the pre-replicative complex |
0.1 | 0.4 | REACTOME_CA_DEPENDENT_EVENTS | Genes involved in Ca-dependent events |
0.1 | 3.8 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.5 | REACTOME_ANDROGEN_BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 3.5 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
0.1 | 3.4 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 3.5 | REACTOME_KINESINS | Genes involved in Kinesins |
0.1 | 0.7 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.1 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.4 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.8 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.3 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 8.8 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 3.3 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.7 | REACTOME_METABOLISM_OF_NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.1 | 1.2 | REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 2.3 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 18.4 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.7 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.7 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.8 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 1.1 | REACTOME_BOTULINUM_NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.9 | REACTOME_RNA_POL_I_TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 1.9 | REACTOME_TRANSLATION | Genes involved in Translation |
0.1 | 1.6 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.6 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.6 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 2.8 | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.8 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.1 | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 1.0 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.7 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.5 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
0.1 | 0.9 | REACTOME_REGULATION_OF_APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 0.2 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.4 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 2.2 | REACTOME_CGMP_EFFECTS | Genes involved in cGMP effects |
0.1 | 0.8 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.2 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.6 | REACTOME_REGULATION_OF_IFNA_SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.2 | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 0.6 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.3 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.9 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 2.2 | REACTOME_INTERFERON_GAMMA_SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.4 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.5 | REACTOME_RECYCLING_PATHWAY_OF_L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.3 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 4.1 | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.5 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.6 | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 1.5 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 3.7 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.1 | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | Genes involved in Signaling by FGFR in disease |
0.1 | 0.3 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.6 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.3 | REACTOME_SPHINGOLIPID_METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 2.0 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.8 | REACTOME_PHASE_II_CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.1 | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.5 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.4 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.4 | REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.0 | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.7 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.9 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.9 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 2.1 | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.0 | REACTOME_CELL_CYCLE_CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.0 | 0.2 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 1.0 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 1.3 | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.6 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.0 | REACTOME_INFLUENZA_LIFE_CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 5.9 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
0.0 | 0.4 | REACTOME_CIRCADIAN_CLOCK | Genes involved in Circadian Clock |
0.0 | 0.2 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 2.2 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.8 | REACTOME_NETRIN1_SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.6 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.2 | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.5 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.2 | REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.0 | REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR | Genes involved in Signaling by constitutively active EGFR |